1. Diesveld MME, de Klerk S, Cornu P, Strobach D, Taxis K, Borgsteede SD. Management of drug-disease interactions: a best practice from the Netherlands. Int J Clin Pharm. 2021 Dec;43(6):1437-1450. doi: 10.1007/s11096-021-01308-0. Epub 2021 Jul 17. PMID: 34273048.
2. van Tongeren JMZ, Harkes-Idzinga SF, van der Sijs H, Atiqi R, van den Bemt BJF, Draijer LW, Hiel D, Kerremans A, Kremers B, de Leeuw M, Olthoff MV, Pham TK, Valentijn-Robertz R, Tsoi K, Wichers I, de Wit M, Borgsteede SD. The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion. Front Pharmacol. 2020 May 15;11:707. doi: 10.3389/fphar.2020.00707. PMID: 32499701; PMCID: PMC7243438.
3. Huang KY, Tseng PT, Wu YC, Tu YK, Stubbs B, Su KP, Matsuoka YJ, Hsu CW, Lin CH, Chen YW, Lin PY. Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Sci Rep. 2021 Jan 11;11(1):452. doi: 10.1038/s41598-020-79837-3. PMID: 33432057; PMCID: PMC7801657.
4. American Society of Health-System Pharmacists. Propranolol. Drugs.com, 2022. https://www.drugs.com/monograph/propranolol.html
5. Yang MC, Lin KY. Drug-induced Acute Angle-closure Glaucoma: A Review. J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):104-109. doi: 10.5005/jp-journals-10078-1261. PMID: 32435123; PMCID: PMC7221246.
6. Ah-Kee EY, Egong E, Shafi A, Lim LT, Yim JL. A review of drug-induced acute angle closure glaucoma for non-ophthalmologists. Qatar Med J. 2015 May 10;2015(1):6. doi: 10.5339/qmj.2015.6. PMID: 26535174; PMCID: PMC4614311.
7. American Society of Health-System Pharmacists. Diphenhydramine. Drugs.com, 2022. https://www.drugs.com/monograph/diphenhydramine.html
8. Głowacka K, Wiela-Hojeńska A. Pseudoephedrine-Benefits and Risks. Int J Mol Sci. 2021 May 13;22(10):5146. doi: 10.3390/ijms22105146. PMID: 34067981; PMCID: PMC8152226.
9. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005 Aug 8-22;165(15):1686-94. doi: 10.1001/archinte.165.15.1686. PMID: 16087815.
10. Akay S, Ozdemir M. Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy. Can J Cardiol. 2008 Nov;24(11):e86-8. doi: 10.1016/s0828-282x(08)70200-9. PMID: 18987767; PMCID: PMC2644546.
11. American Society of Health-System Pharmacists. Pseudoephedrine. Drugs.com, 2022. https://www.drugs.com/monograph/pseudoephedrine.html